Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months

Area of Science:

• Infectious Diseases
• Microbiology
• Respiratory Medicine

Background:

• The prevalence and etiological role of Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP) in community-acquired lower respiratory tract infections (LRTI) remain underexplored.
• Understanding the epidemiology of these pathogens is crucial for effective diagnosis and treatment strategies in primary care settings.

Purpose of the Study:

• To investigate the incidence and clinical significance of CP and MP in adult LRTI cases within community settings.
• To compare the diagnostic accuracy of polymerase chain reaction (PCR) versus immunoassays for detecting CP and MP.

Main Methods:

• A prospective study involving 3207 adult LRTI patients (including pneumonia and acute bronchitis) recruited by general practitioners and hospital physicians in France.
• Detection of CP and MP using PCR and immunoassays on pharyngeal specimens from 3198 participants.

Main Results:

• PCR detected CP and/or MP in 7.3% of LRTI patients, with higher sensitivity than immunoassays.
• CP was detected in 4.1% of acute bronchitis cases and 3.4% of pneumonia cases; MP was found in 2.3% of bronchitis and 7.3% of pneumonia cases.
• Age under 45 and prior antibiotic use were associated with positive PCR results, while clinical signs were not reliable for diagnosis.

Conclusions:

• CP and MP are significant etiological agents in community-acquired LRTI, diagnosed effectively by PCR.
• The study highlights significant geographic variations and temporal trends in the incidence of CP and MP infections.
• Clinical presentation alone is insufficient for differentiating between CP, MP, and other causes of LRTI.